Literature DB >> 705770

HLA and glioma.

P de Moerloose, M Jeannet, A Martin-Achard, N de Tribolet, R Seiler, N Guanella.   

Abstract

HLA typing of 80 glioma patients was determined and the antigen frequencies were compared with 176 normal controls. Increased phenotypic frequencies of Bw35 and DRw1 were observed, but when P values were corrected by the number of antigens tested (35), the results were no longer significant.

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 705770     DOI： 10.1111/j.1399-0039.1978.tb01311.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN： 0001-2815


  6 in total

1.  Selected human leukocyte antigen class II polymorphisms and risk of adult glioma.

Authors:  Bryan A Bassig; Peter D Inskip; Laurie Burdette; William R Shapiro; Robert G Selker; Howard A Fine; Jay S Loeffler; Peter M Black; Robert Dubrow; Alina V Brenner
Journal:  J Neuroimmunol       Date:  2010-12-30       Impact factor: 3.478

Review 2.  Immunobiologic aspects of the brain and human gliomas. A review.

Authors:  C J Wikstrand; D D Bigner
Journal:  Am J Pathol       Date:  1980-02       Impact factor: 4.307

3.  Brain glioma and human leukocyte antigens (HLA)--is there an association.

Authors:  H K Machulla; F Steinborn; A Schaaf; V Heidecke; N G Rainov
Journal:  J Neurooncol       Date:  2001-05       Impact factor: 4.130

4.  Human leukocyte antigen distribution analysis in North Italian brain Glioma patients: an association with HLA-DRB1*14.

Authors:  Franca R Guerini; Cristina Agliardi; Milena Zanzottera; Serena Delbue; Elisabetta Pagani; Carmine Tinelli; Renzo Boldorini; Pier Giorgio Car; Claudia Veggiani; Pasquale Ferrante
Journal:  J Neurooncol       Date:  2005-11-29       Impact factor: 4.130

5.  Glioma Indian scenario: Is there a human leucocyte antigen association?

Authors:  U Shankarkumar; B Sridharan
Journal:  J Nat Sci Biol Med       Date:  2011-07

6.  HLA-E expression in diffuse glioma: relationship with clinicopathological features and patient survival.

Authors:  Zhifeng Wu; Jingshan Liang; Zheng Wang; Aimin Li; Xing Fan; Tao Jiang
Journal:  BMC Neurol       Date:  2020-02-17       Impact factor: 2.474
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.